Loading...
Treprostinil Platform Expansion Into Lung Diseases Will Drive Powerful Long Term Upside
n/a
n/a
AnalystHighTarget's Fair Value
n/a
1Y
203.3%7D
0.9%1Y
203.3%7D
0.9%You can edit this narrative until Dec 9 6:05 PM. Then, changes will post as Updates.